Espoo, Finland

Matti Vaismaa

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 8.2

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2016-2024

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Matti Vaismaa

Introduction

Matti Vaismaa is a notable inventor based in Espoo, Finland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit specific enzymes. With a total of 4 patents to his name, Vaismaa's work is recognized for its potential impact on medical treatments.

Latest Patents

Among his latest patents, Vaismaa has developed pyran derivatives as CYP11A1 (cytochrome P450 monooxygenase 11A1) inhibitors. These compounds, identified by the formula (I), represent a promising avenue for therapeutic applications. His innovative approach in this area showcases his commitment to advancing pharmaceutical science.

Career Highlights

Matti Vaismaa is currently employed at Orion Corporation, a leading company in the pharmaceutical industry. His role at Orion has allowed him to focus on research and development, contributing to the company's reputation for innovation and excellence in healthcare solutions.

Collaborations

Throughout his career, Vaismaa has collaborated with esteemed colleagues, including David Din Belle and Eija Tiainen. These partnerships have fostered a collaborative environment that enhances the quality and scope of his research.

Conclusion

Matti Vaismaa's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments, demonstrating the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…